• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿南亭——一种心钠素(ANF)的肽拮抗剂。I. 产生菌、发酵、分离及生物活性。

Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity.

作者信息

Weber W, Fischli W, Hochuli E, Kupfer E, Weibel E K

机构信息

Pharma Research Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

出版信息

J Antibiot (Tokyo). 1991 Feb;44(2):164-71. doi: 10.7164/antibiotics.44.164.

DOI:10.7164/antibiotics.44.164
PMID:1849131
Abstract

Anantin, a peptide binding to the receptor of the atrial natriuretic factor (ANF) was isolated from a strain of Streptomyces coerulescens. The molecule consists of 17 natural L-amino acids which form a peptidic ring system. It has a MW of 1,871.0. The chemical composition is C90H111N21O24. The compound was found to bind competitively to ANF-receptors from bovine adrenal cortex (Kd = 0.61 microM). Furthermore, it dose-dependently inhibited the ANF-induced intracellular cyclic guanosine monophosphate accumulation in bovine aorta smooth muscle cells. At the same concentration no agonistic effects were detectable in these cells. Thus, anantin is considered to be the first microbially produced antagonist of the cardiac hormone, ANF.

摘要

阿那替丁是一种与心钠素(ANF)受体结合的肽,从一株天蓝色链霉菌中分离得到。该分子由17个天然L-氨基酸组成,形成一个肽环系统。其分子量为1871.0。化学组成为C90H111N21O24。发现该化合物能与牛肾上腺皮质的ANF受体竞争性结合(解离常数Kd = 0.61微摩尔)。此外,它能剂量依赖性地抑制心钠素诱导的牛主动脉平滑肌细胞内环状鸟苷单磷酸的积累。在相同浓度下,在这些细胞中未检测到激动作用。因此,阿那替丁被认为是第一种由微生物产生的心脏激素心钠素的拮抗剂。

相似文献

1
Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity.阿南亭——一种心钠素(ANF)的肽拮抗剂。I. 产生菌、发酵、分离及生物活性。
J Antibiot (Tokyo). 1991 Feb;44(2):164-71. doi: 10.7164/antibiotics.44.164.
2
Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.
J Antibiot (Tokyo). 1991 Feb;44(2):172-80. doi: 10.7164/antibiotics.44.172.
3
Proteolytic cleavage of atrial natriuretic factor receptor in bovine adrenal membranes by endogenous metalloendopeptidase. Effects on guanylate cyclase activity and ligand-binding specificity.内源性金属内肽酶对牛肾上腺膜中的心钠素受体进行蛋白水解切割。对鸟苷酸环化酶活性和配体结合特异性的影响。
Eur J Biochem. 1992 Oct 15;209(2):717-24. doi: 10.1111/j.1432-1033.1992.tb17340.x.
4
Truncated atrial natriuretic peptide analogs. Comparison between receptor binding and stimulation of cyclic GMP accumulation in cultured vascular smooth muscle cells.截短型心钠素类似物。培养的血管平滑肌细胞中受体结合与环鸟苷酸积累刺激作用的比较。
J Biol Chem. 1986 Oct 5;261(28):12960-4.
5
Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells.心房利钠肽在内皮细胞中的结合及环磷酸鸟苷积累的比较
Biochim Biophys Acta. 1986 Jan 23;885(1):74-9. doi: 10.1016/0167-4889(86)90040-6.
6
Synthesis and biological activity of a linear fragment of the atrial natriuretic factor (ANF).心房利钠因子(ANF)线性片段的合成与生物活性
Biochem Biophys Res Commun. 1985 Sep 30;131(3):1056-62. doi: 10.1016/0006-291x(85)90197-4.
7
Characterization of ANF receptors in cultured renal cortical vascular smooth muscle cells.培养的肾皮质血管平滑肌细胞中ANF受体的特性研究
Am J Physiol. 1991 Mar;260(3 Pt 1):C424-32. doi: 10.1152/ajpcell.1991.260.3.C424.
8
Truncated atrial natriuretic factor analogs retain full agonist activity.截短的心房利钠因子类似物保留了完全激动剂活性。
Can J Physiol Pharmacol. 1991 Oct;69(10):1622-7. doi: 10.1139/y91-240.
9
The biological activity of atrial natriuretic factor cleaved by endoprotease 3.4.24.11.被内肽酶3.4.24.11切割后的心房钠尿肽的生物活性
J Enzyme Inhib. 1991;4(3):267-72. doi: 10.3109/14756369109035850.
10
Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells.大鼠培养血管平滑肌细胞中心房钠尿肽受体的下调及其与环鸟苷酸刺激的相关性
Biochem Biophys Res Commun. 1987 Oct 14;148(1):61-7. doi: 10.1016/0006-291x(87)91076-x.

引用本文的文献

1
LassoPred: a tool to predict the 3D structure of lasso peptides.套索肽预测工具:一种预测套索肽三维结构的工具。
Nat Commun. 2025 Jul 1;16(1):5497. doi: 10.1038/s41467-025-60544-4.
2
Predicting 3D Structures of Lasso Peptides.预测套索肽的三维结构。
Res Sq. 2025 Apr 1:rs.3.rs-4579522. doi: 10.21203/rs.3.rs-4579522/v1.
3
Heterologous expression of lasso peptides with apparent participation in the morphological development in Streptomyces.套索肽的异源表达明显参与链霉菌的形态发育。
AMB Express. 2024 Sep 3;14(1):97. doi: 10.1186/s13568-024-01761-w.
4
Mutexa: A Computational Ecosystem for Intelligent Protein Engineering.Mutexa:智能蛋白质工程的计算生态系统。
J Chem Theory Comput. 2023 Nov 14;19(21):7459-7477. doi: 10.1021/acs.jctc.3c00602. Epub 2023 Oct 12.
5
Classification and Multifaceted Potential of Secondary Metabolites Produced by Group: A Comprehensive Review.类群 A 产生的次生代谢产物的分类和多方面潜力:全面综述。
Molecules. 2023 Jan 17;28(3):927. doi: 10.3390/molecules28030927.
6
Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.核糖体合成和翻译后修饰肽的作用机制。
Chem Rev. 2022 Sep 28;122(18):14722-14814. doi: 10.1021/acs.chemrev.2c00210. Epub 2022 Sep 1.
7
Screening Unveil the Great Potential of Ruminal Bacteria Synthesizing Lasso Peptides.筛选揭示瘤胃细菌合成套索肽的巨大潜力。
Front Microbiol. 2020 Sep 11;11:576738. doi: 10.3389/fmicb.2020.576738. eCollection 2020.
8
Attempting to synthesize lasso peptides using high pressure.尝试使用高压合成套索肽。
PLoS One. 2020 Jun 24;15(6):e0234901. doi: 10.1371/journal.pone.0234901. eCollection 2020.
9
Functional modulation of sarcolemmal K channels by atrial natriuretic peptide-elicited intracellular signaling in adult rabbit ventricular cardiomyocytes.心房利钠肽诱导的细胞内信号对成年兔心室肌细胞膜钾通道功能的调节。
Am J Physiol Cell Physiol. 2020 Jul 1;319(1):C194-C207. doi: 10.1152/ajpcell.00409.2019. Epub 2020 May 20.
10
Do Global Regulators Hold the Key to Production of Bacterial Secondary Metabolites?全球监管机构掌握着细菌次级代谢产物生产的关键吗?
Antibiotics (Basel). 2019 Sep 23;8(4):160. doi: 10.3390/antibiotics8040160.